I3H INAUGURAL CONFERENCE

CONFIRMED SPEAKERS

Bruce Beutler, Nobel Laureate in Medicine (2011)
Marc Feldmann, Lasker Award for Clinical Research (2003)
and
Richard Bergström, Roch Doliveux, Guido Rasi, Paul Rutgeerts, Bettina Ryll, Sander van Deventer, Jean-Louis Vincent
PROGRAM

Morning session: “Innovation for health”

Chairs: Eric DE KEULENEER (Chairman, ULB Board) & Peter ‘O DONNELL, Associate Editor, Politico (tbc)

10h00 – 10h20:

Richard BERGSTROM

Director General, European Federation of Pharmaceutical Industries and Associations

” Innovation for health: the commitment of the biopharmaceutical industry”

10h20 – 10h40

Guido RASI

Principal Adviser, European Medicines Agency

” The evolving role of regulatory agencies”

10h40 – 11h10: coffee break

11h10 – 11h30

Sander van DEVENTER

Managing Partner at Forbion Biocapital & Professor at Leiden University Medical Center

” Financial incentives to boost innovation: what is needed?

11h30 – 11h50

Jean-Louis VINCENT

President, World Federation of Societies of Intensive and Critical Care Medicine & Professor at Université libre de Bruxelles

” Clinical trials: who is responsible for what ?”

11h50 – 12h10

Bettina RYLL

Founder, Melanoma Patient Network

” A societal perspective: Time for changes !”

12h10-13h00 Round table

Patient-centric innovation: what does it mean ?”

————————————————————————————————————————–

Afternoon session: “Anti-TNF therapy, a paradigm for biopharmaceutical innovation”

Chairs: Michel GOLDMAN, I3h Founder,  & Andrew JACK, Editor, Financial Times

14:00 – 14:30

Bruce BEUTLER, Nobel Prize Laureate in Medicine 2011, University of Texas Southwestern Medical Center, USA

“The discovery of new targets for inflammatory disorders”

14:30 – 15:00

Sir Marc FELDMANN, Laureate of Albert Lasker Award 2003, Kennedy Institute of Rheumatology, University of Oxford, UK

“Pioneering anti-TNF therapy: lessons learned point path to future progress?”

15:00 – 15:30

Paul RUTGEERTS, Emeritus Professor of Medicine, KU Leuven

“Targeting cytokines in inflammatory bowel disease: clinical research at the forefront”

15:30 – 16:00

Roch DOLIVEUX,  Chairman of the Board at Vlerick Business School, retired CEO of UCB, and past-Chair of the IMI Governing Board

“Bringing new biologicals to patients: the mission of the research-based pharmaceutical industry”

16:00 – 16:30: Coffee break

16:30 – 17h15: Round table

What did we learn from the anti-TNF journey ?”

17h30: Cocktail-reception

Exhibition

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ornare, neque et finibus viverra, nulla ex semper sapien, condimentum cursus dolor eros sed nibh. Fusce id eros sit amet ex iaculis luctus. Nullam ornare sollicitudin erat, a porttitor quam euismod eu. Quisque quis fermentum ligula, maximus accumsan sapien. Aenean sed aliquet lacus, non viverra nulla.

List of participants

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ornare, neque et finibus viverra, nulla ex semper sapien, condimentum cursus dolor eros sed nibh. Fusce id eros sit amet ex iaculis luctus. Nullam ornare sollicitudin erat, a porttitor quam euismod eu. Quisque quis fermentum ligula, maximus accumsan sapien. Aenean sed aliquet lacus, non viverra nulla.

Speakers corner

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ornare, neque et finibus viverra, nulla ex semper sapien, condimentum cursus dolor eros sed nibh. Fusce id eros sit amet ex iaculis luctus. Nullam ornare sollicitudin erat, a porttitor quam euismod eu. Quisque quis fermentum ligula, maximus accumsan sapien. Aenean sed aliquet lacus, non viverra nulla.

Press corner

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ornare, neque et finibus viverra, nulla ex semper sapien, condimentum cursus dolor eros sed nibh. Fusce id eros sit amet ex iaculis luctus. Nullam ornare sollicitudin erat, a porttitor quam euismod eu. Quisque quis fermentum ligula, maximus accumsan sapien. Aenean sed aliquet lacus, non viverra nulla.

Background information

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ornare, neque et finibus viverra, nulla ex semper sapien, condimentum cursus dolor eros sed nibh. Fusce id eros sit amet ex iaculis luctus. Nullam ornare sollicitudin erat, a porttitor quam euismod eu. Quisque quis fermentum ligula, maximus accumsan sapien. Aenean sed aliquet lacus, non viverra nulla.

By | 2017-10-31T17:48:04+00:00 July 1st, 2015|EVENTS|0 Comments